Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies

NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies

Zouhair Souissi

Bibliographie

23 avril 2021

NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health

The post NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies appeared first on Links Medicus.

Lu 701 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized Covid-19: More data on the increased risks to pregnant women and their newborn infants »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche